Gregory Forlenza, MD

Trials

Studies that name Gregory Forlenza, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:36 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06865989 · Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

  Insulet Corporation · completed · Diabetes Mellitus, Type 1, Type 2 · study chair
• N/A
  NCT06177691 · Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

  Jaeb Center for Health Research · completed · Type1 Diabetes · study chair
• Early Ph1
  NCT05006040 · HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL

  University of Colorado, Denver · terminated · High Risk Acute Lymphoblastic Leukemia · principal investigator
• Ph3
  NCT04233034 · Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

  Jaeb Center for Health Research · completed · Type1 Diabetes · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Genomics Shared Resource
  P30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · fiscal years 2009 to 2026
  Named on NCT05006040